Seizert Capital Partners, LLC Kamada LTD Transaction History

Seizert Capital Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$5.21 - $6.82 $813,671 - $1.07 Million	-156,175 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$5.25 - $5.87 $327,311 - $365,965	62,345 Added 66.44%	156,175 $828,000
Q2 2021 Aug 05, 2021	BUY	$5.67 - $6.33 $271,128 - $302,687	47,818 Added 103.93%	93,830 $546,000
Q4 2020 Feb 08, 2021	BUY	$6.3 - $8.46 $157,084 - $210,941	24,934 Added 118.29%	46,012 $298,000
Q3 2020 Nov 03, 2020	SELL	$8.02 - $11.73 $41,030 - $60,010	-5,116 Reduced 19.53%	21,078 $176,000
Q2 2020 Aug 06, 2020	SELL	$5.37 - $9.45 $93,894 - $165,233	-17,485 Reduced 40.03%	26,194 $203,000
Q1 2020 May 05, 2020	BUY	$4.56 - $7.13 $69,421 - $108,547	15,224 Added 53.5%	43,679 $255,000
Q4 2019 Feb 10, 2020	BUY	$4.97 - $7.7 $141,421 - $219,103	28,455 New	28,455 $194,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Seizert Capital Partners, LLC with notifications on news.